AI Verdict
MCK has stronger fundamentals based on our AI analysis.
CVS vs MCK Fundamental Comparison
| Metric | CVS | MCK |
|---|---|---|
| Revenue | $402.1B | $307.1B |
| Net Income | $1.8B | $3.1B |
| Net Margin | 0.4% | 1.0% |
| ROE | 2.4% | N/A |
| ROA | 0.7% | 3.7% |
| Current Ratio | 0.84x | 0.88x |
| Debt/Equity | 0.85x | N/A |
| EPS | $1.39 | $24.73 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
CVS vs MCK: Frequently Asked Questions
Is CVS or MCK a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), MCK has stronger fundamentals. CVS is rated HOLD (70% confidence) while MCK is rated BUY (70% confidence). This is not investment advice.
How does CVS compare to MCK fundamentally?
CVS HEALTH Corp has ROE of 2.4% vs MCKESSON CORP's N/A. Net margins are 0.4% vs 1.0% respectively.
Which stock pays higher dividends, CVS or MCK?
CVS has a dividend yield of N/A or no dividend while MCK has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in CVS or MCK for long term?
For long-term investing, consider that CVS has HOLD rating with 70% confidence, while MCK has BUY rating with 70% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about CVS vs MCK?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For CVS vs MCK, the AI consensus favors MCK based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.